{
  "id": 20535938,
  "title": "CJ OliveNetworks brings AI-powered inspections to pharmaceutical factory",
  "url": "https://urgent.news/2026/11/18/cj-olivenetworks-brings-ai-powered-inspections-to-pharmaceutical",
  "topic": "ai",
  "section": "AI",
  "published": "2026-11-18T03:02:03.000Z",
  "source": {
    "name": "The Korea Times",
    "slug": "the-korea-times-koreatimes",
    "url": "https://www.koreatimes.co.kr/business/companies/20261118/cj-olivenetworks-brings-ai-powered-inspections-to-pharmaceutical-factory"
  },
  "original_language": "en",
  "account": "CJ OliveNetworks is introducing AI-powered inspections to WiseMedi's pharmaceutical manufacturing facility in Jincheon, North Chungcheong Province. This initiative aims to enhance production reliability and quality control. The company, led by CEO Yoo In-sang, plans to create an AI-powered smart factory for WiseMedi, a subsidiary of Yuhan specializing in intravenous fluid manufacturing. The project is supported by the government's Shared Growth AI (AI transformation) Leading Model Support Program.\n\nA key component of this transformation will be AI-powered visual inspection, which will scrutinize each product for packaging defects such as uneven seals and folded sections. This system will be linked to robots that automatically exclude any products identified as defective. The company aims for a detection accuracy of at least 95 percent.",
  "summary": "CJ OliveNetworks is bringing artificial intelligence (AI) into pharmaceutical manufacturing, deploying automated inspection and equipment monitoring systems at WiseMedi’s second plant in Jincheon, North Chungcheong Province, in a push to improve production reliability and quality control. CJ OliveNetworks, led by CEO Yoo In-sang, said Wednesday it would build an AI-powered smart factory for…",
  "key_points": [
    "CJ OliveNetworks introduces AI-powered inspections at WiseMedi's pharmaceutical factory.",
    "AI system checks products for packaging defects with 95% detection accuracy.",
    "Project funded by government's Shared Growth AI Leading Model Support Program."
  ],
  "editors_take": "Integrating automated visual inspections into pharmaceutical manufacturing shifts quality control from manual oversight to robotic precision, reducing human error in the production of intravenous fluids.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}